1-4 of 4
Cathelijne Alleman
Close
Sort by
Journal Articles

Systematic Literature Review of the Clinical Evidence in Relapsed/Refractory (R/R) Large B-Cell Lymphoma

David G. Maloney, MD PhD, Fei Fei Liu, Lisette Nientker, Cathelijne Alleman, Brian Hutton, PhD, Jacob Garcia, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5821.
https://doi.org/10.1182/blood-2019-127664
Published: 2019
Journal Articles

The Burden of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): A Systematic Literature Review (SLR)

Georg Lenz, Sarah C. Rutherford, Andrew Davies, Pier Luigi Zinzani, MD, Gilles Salles, MD PhD, Jens Hasskarl, Sandra Margunato-Debay, Filipe Rodrigues, Lisette Nientker, Janita Balradj, Cathelijne Alleman
Journal: Blood
Blood (2018) 132 (Supplement 1): 2241.
https://doi.org/10.1182/blood-2018-99-112878
Published: 2018
Journal Articles

Overall Economic Burden of Total Treatment Costs in Acute Myeloid Leukemia throughout the Course of the Disease

Dalia Mahmoud, MBA, Barry S. Skikne, MD, Izabela Kucmin-Bemelmans, MSc, Cathelijne Alleman, MSc, Marja Hensen, MSc
Journal: Blood
Blood (2012) 120 (21): 3614.
https://doi.org/10.1182/blood.V120.21.3614.3614
Published: 2012
Journal Articles

Cost-Effectiveness of Treatment of Childhood Acute Lymphoblastic Leukemia with Pegasparaginase and Erwinia Asparaginase: The Impact of Expensive Chemotherapy

Wing H. Tong, MD, Inge M. van der Sluis, MD, PhD, Cathelijne Alleman, MSc, Raphaele RL van Litsenburg, MD, PhD, Gertjan Kaspers, MD, PhD, Rob Pieters, MD, PhD, Carin A. Uyl-de Groot, PhD
Journal: Blood
Blood (2012) 120 (21): 4227.
https://doi.org/10.1182/blood.V120.21.4227.4227
Published: 2012